Global Alzheimer’s P
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Eli Lilly and Company for the Transformative Bio-Hermes-002 Study
09 déc. 2024 10h00 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Eli Lilly and Company (Lilly) to the Bio-Hermes-002 study. This...
Clinical Trial Supplies Market
Clinical Trial Supplies Industry Forecast Report 2025-2033: $4.79 Billion Market Soars as Chronic Disease Incidence Rises Globally
05 déc. 2024 04h31 HE | Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Global Forecast Report by Services, Phase, Therapeutic Area, End Use, Countries and Company Analysis 2025-2033" report...
Picture2.jpg
Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials
04 déc. 2024 08h00 HE | Adaptive Research Inc
Western Radiation Oncology has joined Adaptive Research’s growing network of community physician practices.
Clinical Trial Investigative Site Network Market
Clinical Trial Investigative Site Network Market Analysis Report 2025-2030, Featuring ICON, IQVIA, WCG Clinical, ClinChoice, SGS, FOMAT Medical Research, SMO-Pharmina, Xylem Research and More
03 déc. 2024 05h15 HE | Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report by Therapeutic Areas (Oncology, Cardiology), Phase (Phase I,...
22157.jpg
Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insights Report 2024-2029: Innovent, MabWorks, and Biotheus are Making Substantial Progress
22 nov. 2024 04h49 HE | Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. ...
Science 37 Logo.jpg
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
21 nov. 2024 08h00 HE | Science 37, Inc.
Science 37 contributes almost half (47%) of the U.S. enrollment for GSK Phase 3 rare disease study while bolstering participant retention figures.
2025 MDA Clinical & Scientific Conference
Agenda Announced for 2025 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease
14 nov. 2024 09h00 HE | Muscular Dystrophy Association
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association today announced the agenda including tracks and Chairs for the 2025 MDA Clinical & Scientific Conference being held...
medeloop.png
Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research
13 nov. 2024 08h00 HE | Medeloop
MENLO PARK, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round. Led by global venture...
Transparency Market Research
Next Generation Sequencers (NGS) Market Set to Surge at 8.3% CAGR, to Reach USD 2.4 billion by 2031 | Transparency Market Research, Inc.
08 nov. 2024 07h32 HE | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The next generation sequencers (NGS) industry (차세대 시퀀서(NGS) 산업) was valued at US$ 1.2...
Collaborative effort
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
28 oct. 2024 10h00 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These...